Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Bain Capital Specialty Finance downgraded to Neutral from Buy at BofA » 06:27
06/29/20
06/29
06:27
06/29/20
06:27
BCSF

Bain Capital Specialty Finance

$11.03 /

-0.28 (-2.48%)

BofA analyst Derek Hewett…

BofA analyst Derek Hewett resumed coverage and downgraded Bain Capital Specialty Finance to Neutral from Buy with a $12 price target. The company's recently completed capital offerings improved liquidity and increased financial flexibility amid uncertain economic outlook but were also dilutive to its earnings and net asset value per share, the analyst tells investors in a research note. Hewett further cites Bain Capital's plans to cut its dividend by 17% starting in Q2 behind his rating change.

ShowHide Related Items >><<
BCSF Bain Capital Specialty Finance
$11.03 /

-0.28 (-2.48%)

BCSF Bain Capital Specialty Finance
$11.03 /

-0.28 (-2.48%)

04/01/20 Janney Montgomery Scott
Janney Montgomery Scott downgrades four BDCs based on COVID-19 recession
04/01/20 Janney Montgomery Scott
Bain Capital Specialty Finance downgraded to Neutral from Buy at Janney Montgomery Scott
01/27/20 Keefe Bruyette
Bain Capital downgraded to Market Perform from Outperform at Keefe Bruyette
01/15/20 Wells Fargo
Bain Capital Specialty Finance downgraded on valuation at Wells Fargo
BCSF Bain Capital Specialty Finance
$11.03 /

-0.28 (-2.48%)

BCSF Bain Capital Specialty Finance
$11.03 /

-0.28 (-2.48%)

Over a quarter ago
Earnings
Bain Capital Specialty Finance reports Q1 NII 44c, consensus 41c » 17:35
05/04/20
05/04
17:35
05/04/20
17:35
BCSF

Bain Capital Specialty Finance

$9.21 /

-0.48 (-4.95%)

Net asset value per share…

Net asset value per share for the quarter ended March 31 was $17.29 as compared to $19.72 for the quarter ended December 31, 2019, representing a 12% decline quarter-over-quarter.

ShowHide Related Items >><<
BCSF Bain Capital Specialty Finance
$9.21 /

-0.48 (-4.95%)

04/01/20 Janney Montgomery Scott
Janney Montgomery Scott downgrades four BDCs based on COVID-19 recession
04/01/20 Janney Montgomery Scott
Bain Capital Specialty Finance downgraded to Neutral from Buy at Janney Montgomery Scott
01/27/20 Keefe Bruyette
Bain Capital downgraded to Market Perform from Outperform at Keefe Bruyette
01/15/20 Wells Fargo
Bain Capital Specialty Finance downgraded on valuation at Wells Fargo
Downgrade
Janney Montgomery Scott downgrades four BDCs based on COVID-19 recession » 08:02
04/01/20
04/01
08:02
04/01/20
08:02
BCSF

Bain Capital Specialty Finance

$9.27 /

+0.01 (+0.11%)

, MRCC

Monroe Capital

$7.01 /

+0.405 (+6.14%)

, OFS

OFS Capital

$4.05 /

-0.16 (-3.80%)

, SCM

Stellus Capital

$7.30 /

-0.09 (-1.22%)

As previously reported,…

As previously reported, Janney Montgomery Scott analyst Mitchel Penn downgraded Bain Capital Specialty Finance (BCSF), Monroe Capital (MRCC), OFS Capital (OFS) and Stellus Capital (SCM), all to Neutral from Buy, as he lowered his equity fair value for all 30 BDCs, or Business Development Companies, he covers to account for credit, liquidity, and leverage pressures based on his view that the COVID-19 pandemic will likely cause a recession. Credit losses are likely to be higher than historic levels as "some good companies are likely to be impaired," but he doesn't think BDC bonds will likely be impaired as BDCs take actions to preserve capital such as suspending equity dividends or paying dividends in stock or rights offerings, Penn tells investors.

ShowHide Related Items >><<
BCSF Bain Capital Specialty Finance
$9.27 /

+0.01 (+0.11%)

04/01/20 Janney Montgomery Scott
Bain Capital Specialty Finance downgraded to Neutral from Buy at Janney Montgomery Scott
01/27/20 Keefe Bruyette
Bain Capital downgraded to Market Perform from Outperform at Keefe Bruyette
01/15/20 Wells Fargo
Bain Capital Specialty Finance downgraded on valuation at Wells Fargo
01/15/20 Wells Fargo
Bain Capital downgraded to Underweight from Equal Weight at Wells Fargo
MRCC Monroe Capital
$7.01 /

+0.405 (+6.14%)

04/01/20 Janney Montgomery Scott
Monroe Capital downgraded to Neutral from Buy at Janney Montgomery Scott
OFS OFS Capital
$4.05 /

-0.16 (-3.80%)

04/01/20 Janney Montgomery Scott
OFS Capital downgraded at Janney Montgomery Scott
11/11/19 Ladenburg
OFS Capital downgraded to Neutral after prior price target achieved at Ladenburg
11/11/19 Ladenburg
OFS Capital downgraded to Neutral from Buy at Ladenburg
08/05/19 Ladenburg
OFS Capital upgraded to Buy from Neutral at Ladenburg
SCM Stellus Capital
$7.30 /

-0.09 (-1.22%)

04/01/20 Janney Montgomery Scott
Stellus Capital downgraded to Neutral from Buy at Janney Montgomery Scott
08/12/19
Stellus Capital downgraded to Perform at Oppenheimer
08/11/19 Oppenheimer
Stellus Capital downgraded to Perform from Outperform at Oppenheimer
Downgrade
Bain Capital Specialty Finance downgraded to Neutral from Buy at Janney Montgomery Scott » 07:31
04/01/20
04/01
07:31
04/01/20
07:31
BCSF

Bain Capital Specialty Finance

$9.27 /

+0.01 (+0.11%)

Janney Montgomery Scott…

Janney Montgomery Scott analyst Mitchel Penn downgraded Bain Capital Specialty Finance to Neutral from Buy with a $9 price target.

ShowHide Related Items >><<
BCSF Bain Capital Specialty Finance
$9.27 /

+0.01 (+0.11%)

01/27/20 Keefe Bruyette
Bain Capital downgraded to Market Perform from Outperform at Keefe Bruyette
01/15/20 Wells Fargo
Bain Capital Specialty Finance downgraded on valuation at Wells Fargo
01/15/20 Wells Fargo
Bain Capital downgraded to Underweight from Equal Weight at Wells Fargo
04/24/19 JMP Securities
Bain Capital Specialty Finance initiated with a Market Perform at JMP Securities
Hot Stocks
Bain Capital Specialty Finance issues letter to shareholders regarding COVID-19 » 08:43
03/30/20
03/30
08:43
03/30/20
08:43
BCSF

Bain Capital Specialty Finance

$10.76 /

-0.33 (-2.98%)

Bain Capital Specialty…

Bain Capital Specialty Finance announced that it issued an open letter to its shareholders regarding a business update amid COVID-19 pandemic. The letter follows: "The emergence and rapid escalation of COVID-19 has deeply impacted all areas of our lives in ways we never thought possible. While every dislocation is different, our experience successfully navigating through a number of other periods of extreme volatility has shown us the importance of transparency and regular communication both internally and externally. As you turn your focus on the health and wellbeing of you and your loved ones during these uncertain times, Bain Capital remains dedicated to safeguarding your investment in BCSF. We want to provide an update on the steps we are taking to effectively manage the portfolio through this challenging time. We are fully operational, and the global reach and cross-platform dialogue among Bain Capital's business lines is a clear advantage for our Private Credit Group as we all navigate the current environment. We have been in constant dialogue with the management teams of our portfolio companies and the private equity sponsors who own them. These conversations are just a component of our proactive approach to portfolio management. We want to use this opportunity to share our observations, provide an update on portfolio composition, and highlight the steps we are taking, including raising both new equity and debt capital, to position the Company to weather this storm while preparing to pursue new potential investment opportunities... At this stage it is too early to know how effective the containment measures being put in place will prove to be in terms of stalling the spread of the virus and allowing a return to greater economic activity. As a result, we are preparing for the continuation of an uncertain environment in the near-term. Some of the additional measures we have taken include: Frequent communication with our portfolio company management teams and related private equity sponsors in order to understand contemporary and expected financial performance; Re-underwriting each of our 114 portfolio companies in order to understand how they can be expected to perform if economic activity remains suppressed for an extended period of time; and Building an internal watch list so we are poised to quickly engage with these companies and their private equity sponsors... As a further precaution, effective March 27, 2020, we entered into a backup revolver arrangement with our Advisor with a maximum credit limit of $50 million and an expiration date of March 27, 2023. We believe the increased capacity available under this facility will provide us with sufficient liquidity to navigate the current market conditions and dry powder as we consider new investment opportunities. The establishment of this facility is further evidence of the support and conviction our Advisor has in the Company's business objectives, and the broader benefits the Company derives from its relationship to the Bain Capital platform. We are also actively pursuing opportunities for BCSF to benefit from the recently enacted CARES Act that provides a $2 trillion stimulus package for individual taxpayers and U.S. small businesses...In addition to the above steps, following deliberations with our independent board members, we have filed an N-2 with the U.S. Securities and Exchange Commission today to seek to raise additional equity capital through a rights offering to existing investors. We believe raising additional equity now allows us to further strengthen our balance sheet and provide additional flexibility to support our existing portfolio companies over the coming months. We believe this ultimately will also enable us to be creative and forward-leaning at a time when many other middle market companies will be seeking additional financing and other liquidity providers may be retreating... While the COVID-19 pandemic is surely a fast evolving situation with multiple layers of complexity, we believe market conditions should ultimately favor long-term minded, value-oriented, fundamental investors. This has been at the core of Bain Capital Credit's approach since our founding in 1998. Rest assured the Company is well equipped to navigate the current environment as we remain focused on prudently managing the portfolio and our steady stewardship of your capital. We believe our investment, portfolio, and liability construction decisions have been well informed by the experience of the many investment and operating professionals at Bain Capital who have successfully navigated multiple market cycles and disruptions. As a business development company, we take our commitment to lending to middle market companies across the country and around the world seriously. Finally, we would like to thank all of you for your continued support as we navigate through this period together."

ShowHide Related Items >><<
BCSF Bain Capital Specialty Finance
$10.76 /

-0.33 (-2.98%)

01/27/20 Keefe Bruyette
Bain Capital downgraded to Market Perform from Outperform at Keefe Bruyette
01/15/20 Wells Fargo
Bain Capital Specialty Finance downgraded on valuation at Wells Fargo
01/15/20 Wells Fargo
Bain Capital downgraded to Underweight from Equal Weight at Wells Fargo
04/24/19 JMP Securities
Bain Capital Specialty Finance initiated with a Market Perform at JMP Securities
Downgrade
Bain Capital downgraded to Market Perform from Outperform at Keefe Bruyette » 04:48
01/27/20
01/27
04:48
01/27/20
04:48
BCSF

Bain Capital Specialty Finance

$19.77 /

-0.08 (-0.40%)

Keefe Bruyette analyst…

Keefe Bruyette analyst Ryan Lynch downgraded Bain Capital Specialty Finance to Market Perform from Outperform with an unchanged price target of $19.50. The analyst cites primarily valuation for the downgrade. Further, while he still likes the management team and broader credit platform, he does not see a near-term catalyst to move the stock meaningfully higher given its "stagnant" earnings and dividend.

ShowHide Related Items >><<
BCSF Bain Capital Specialty Finance
$19.77 /

-0.08 (-0.40%)

01/15/20 Wells Fargo
Bain Capital Specialty Finance downgraded on valuation at Wells Fargo
01/15/20 Wells Fargo
Bain Capital downgraded to Underweight from Equal Weight at Wells Fargo
04/24/19 JMP Securities
Bain Capital Specialty Finance initiated with a Market Perform at JMP Securities
Periodicals
Global investment firms 'swoop' in to buy defaulted Chinese loans, WSJ says » 14:26
01/21/20
01/21
14:26
01/21/20
14:26
BX

Blackstone

$61.57 /

+0.78 (+1.28%)

, OAK

Oaktree Capital

$0.00 /

+ (+0.00%)

, BCSF

Bain Capital Specialty Finance

$19.67 /

-0.015 (-0.08%)

Global investment firms…

Global investment firms including Blackstone Group (BX), Lone Star Funds and Oaktree Capital (OAK) as well as Bain Capital (BCSF) have invested more than $3B in nonperforming Chinese commercial loans, reports the Wall Street Journal. "China's bad-debt problem is growing, and U.S. investors are trying to cash in," said Andrew Brown, a senior advising partner at ShoreVest Partners, according to the WSJ story. Reference Link

ShowHide Related Items >><<
BX Blackstone
$61.57 /

+0.78 (+1.28%)

01/13/20 Credit Suisse
Brookfield price target raised to $68 from $60 at Credit Suisse
12/19/19 Wells Fargo
Wells stays bullish on alternative asset managers into 2020, Ares top pick
11/01/19
Rice University-Jones Graduate School of Business to hold a summit
10/15/19 Citi
Tallgrass Energy downgraded to Neutral from Buy at Citi
OAK Oaktree Capital
$0.00 /

+ (+0.00%)

03/14/19 Wells Fargo
Oaktree Capital price target raised to $49 from $44 at Wells Fargo
03/14/19 Morgan Stanley
Oaktree Capital downgraded to Equal Weight from Overweight at Morgan Stanley
BCSF Bain Capital Specialty Finance
$19.67 /

-0.015 (-0.08%)

01/15/20 Wells Fargo
Bain Capital Specialty Finance downgraded on valuation at Wells Fargo
01/15/20 Wells Fargo
Bain Capital downgraded to Underweight from Equal Weight at Wells Fargo
04/24/19 JMP Securities
Bain Capital Specialty Finance initiated with a Market Perform at JMP Securities
Downgrade
Bain Capital Specialty Finance downgraded on valuation at Wells Fargo » 06:39
01/15/20
01/15
06:39
01/15/20
06:39
BCSF

Bain Capital Specialty Finance

$19.90 /

+0.03 (+0.15%)

Wells Fargo analyst…

Wells Fargo analyst Finian O'Shea downgraded Bain Capital Specialty Finance to Underweight from Equal Weight with a price target of $18.50, up from $18. In a research note to investors, O'Shea says that while he made the ratings change based on valuation, he continues to view Business Development Companies positively given a benign credit environment and meaningful spread to short end benchmark rates. He continues to view the industry's growth as a major positive as credit is being managed in much better hands, but sees some concern over investor base and fee structure that could hold back individual names.

ShowHide Related Items >><<
BCSF Bain Capital Specialty Finance
$19.90 /

+0.03 (+0.15%)

01/15/20 Wells Fargo
Bain Capital downgraded to Underweight from Equal Weight at Wells Fargo
04/24/19 JMP Securities
Bain Capital Specialty Finance initiated with a Market Perform at JMP Securities
Downgrade
Bain Capital downgraded to Underweight from Equal Weight at Wells Fargo » 04:50
01/15/20
01/15
04:50
01/15/20
04:50
BCSF

Bain Capital Specialty Finance

$19.90 /

+0.03 (+0.15%)

Wells Fargo analyst…

Wells Fargo analyst Finian O'Shea downgraded Bain Capital Specialty Finance to Underweight from Equal Weight with an $18.50 price target.

ShowHide Related Items >><<
BCSF Bain Capital Specialty Finance
$19.90 /

+0.03 (+0.15%)

04/24/19 JMP Securities
Bain Capital Specialty Finance initiated with a Market Perform at JMP Securities

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.